Bessede A, Peyraud F, Besse B, Cousin S, et al. TROP2 is associated with primary resistance to immune checkpoint inhibition in patients with advanced non-small cell lung cancer. Clin Cancer Res 2023 Dec 1. doi: 10.1158/1078-0432.CCR-23-2566.
PMID: 38048058